CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTCBB: NVIV), a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that the Company will be presenting at the 13th Annual Rodman & Renshaw Healthcare Conference being held at the Waldorf Astoria in New York City from September 11th – 13th. Frank Reynolds, CEO of InVivo, will deliver the Company’s corporate presentation and provide an update on its business on Tuesday, September 13th, at 4:05 p.m. Eastern time.
The presentation will be webcast live at http://www.wsw.com/webcast/rrshq20/nviv and on the Investor Relations section of the Company’s website at www.invivotherapeutics.com, where it will also be archived for 90 days.
The Company will be available for one-on-one meetings with investors participating in the Rodman & Renshaw Healthcare Conference. For those who would like to schedule an appointment with InVivo management, please contact Kim Sutton Golodetz of LHA at 212-838-3777 or at firstname.lastname@example.org, or contact your Rodman & Renshaw representative.
About InVivo Therapeutics
InVivo Therapeutics Holdings Corp. is focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company was founded in 2005 on the basis of proprietary technology co-invented by Robert Langer, ScD. Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who is affiliated with Massachusetts General Hospital.
For more information please visit InVivo’s web site at www.invivotherapeutics.com.